Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04940988 · ClinicalTrials.gov registry record

Impacts of a Physician-targeted Price Transparency Tool on Medication Out-of-pocket Costs

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
21,401
Enrollment target

NCT04940988 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 21,401 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04940988 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
21,401 participants
Enrollment target

Study Summary

The goal of this study is to evaluate whether presenting patient out-of-pocket cost information to the provider at the time of prescribing leads to orders for medications with lower out-of-pocket costs. The Real-Time Prescription Benefits (RTPB) tool has been implemented to randomly selected providers across NYU Langone Health's outpatient physician practices. The RTPB tool provides physicians with information about patient out-of-pocket (OOP) cost for medications at the point of outpatient prescribing. OOP is inclusive of any copay, coinsurance, and deductible that the patient owes given their prescription drug benefit plan. If the physician is submitting a prescription order and a clinically-appropriate alternative with a lower OOP cost is available, an alert with OOP cost information for the drug being initially ordered as well as up to three lower-cost alternatives will be displayed. Implementation of this tool will be analyzed to see if it will lead to reduced out-of-pocket costs on ordered medications when alternatives were available. Because effects could vary along many dimensions (e.g., specialty, drug class, insurance type), secondary analyses will be conducted and stratified along such dimensions. Analyses will be conducted at the prescription order level.

Interventions

  • OTHER Real-time benefits check

Trial Details

FieldValue
Enrollment Target 21,401 participants
Start Date 2020-11-18
Est. Completion 2021-07-30

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04940988

The ClinicalTrials.gov registry entry for NCT04940988 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21,401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Real-time benefits check is the first listed.

NCT04940988 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04940988 about?

NCT04940988 is a clinical study titled "Impacts of a Physician-targeted Price Transparency Tool on Medication Out-of-pocket Costs". The goal of this study is to evaluate whether presenting patient out-of-pocket cost information to the provider at the time of prescribing leads to orders for medications with lower out-of-pocket costs. The Real-Time Prescription Benefits (RTPB) tool has been implemented to randomly selected provide...

What is the current status of trial NCT04940988?

This trial is currently completed. The enrollment target is 21,401 participants. The study started on 2020-11-18. Estimated completion is 2021-07-30.

What interventions are being tested in trial NCT04940988?

The interventions under investigation include: Real-time benefits check (OTHER).

Who is sponsoring clinical trial NCT04940988?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.